Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment

Peter M. ten Klooster, Martine M. Veehof, Erik Taal, Piet L.C.M. van Riel, Mart A.F.J. van de Laar

Research output: Contribution to journalArticleAcademicpeer-review

49 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry